Close Menu

This article has been updated to include comments from Xifin Executive Chairman and CEO Lale White.

NEW YORK (360Dx) – New Medicare reimbursement rates for lab tests implemented at the start of the year under the Protecting Access to Medicare Act could lead to billions in excess Medicare payments to laboratories in the years ahead, according to a new report from the US Government Accountability Office.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.